TECXTectonic Therapeutic, Inc.
$22.68+52% 1Y
$22.68
$15.3652 weeks$37.82
TECX as reported
- Net income
- −$86M
Net income · +30% year on year · trailing twelve months to Q2 2026
- Free cash flow
- −$72M
Free cash flow · +12% year on year · trailing twelve months to Q2 2026
- EPS
- −$4.57
EPS · +59% year on year · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Net income | −$86M | +30% | Q2 2026 |
| EPS | −$4.57 | +59% | Q2 2026 |
| ROE | −32% | n/a | Q2 2026 |
| ROA | −31% | n/a | Q2 2026 |
| ROIC | −1714% | n/a | Q1 2023 · 13 quarters behind |
| Free cash flow | −$72M | +12% | Q2 2026 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Tectonic Therapeutic, Inc. (TECX) · Net incomeNet incomeTectonic Therapeutic, Inc. (TECX)